Clearfield (CLFD) closed the last trading session at $36.36, gaining 37.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $46 indicates a 26.5% upside potential.The average comprises four short-term price targets ranging from a low of $44 to a high of $50, with a standard deviation of $2.71. While the lowest estimate indicates an increase of 21% from the current price level, the m ...

Core Viewpoint - Easterly Government Properties (DEA) has shown a slight increase of 0.1% in share price over the past four weeks, closing at $20.92, with a potential upside of 35% based on Wall Street analysts' mean price target of $28.25 [1][11]. Price Targets and Analyst Estimates - The mean estimate for DEA comprises five short-term price targets with a standard deviation of $3.26, indicating variability among analysts. The lowest estimate suggests a 13.5% increase to $23.75, while the highest target predicts a 55.4% surge to $32.50 [2][9]. - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Market Sentiment - Analysts are optimistic about DEA's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with near-term stock price movements [11][12]. - The Zacks Consensus Estimate for DEA has increased by 0.8% over the past month, reflecting a positive revision trend with no negative adjustments [12]. Zacks Rank and Investment Potential - DEA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside in the near term [13].

Shares of Braze, Inc. (BRZE) have gained 10.8% over the past four weeks to close the last trading session at $33.66, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $51.37 indicates a potential upside of 52.6%.The mean estimate comprises 19 short-term price targets with a standard deviation of $10.18. While the lowest estimate of $38 indicates a 12.9% increase from the current p ...

Core Viewpoint - Universal Health Services (UHS) shares have increased by 2.4% recently, closing at $178.74, with a potential upside of 26.3% based on Wall Street analysts' mean price target of $225.81 [1] Price Targets - The average of 16 short-term price targets ranges from a low of $198 to a high of $280, with a standard deviation of $21.94, indicating variability among analysts [2] - The lowest estimate suggests a 10.8% increase from the current price, while the highest estimate indicates a 56.7% upside [2] Analyst Sentiment - Analysts show a consensus that UHS will report better earnings than previously estimated, which historically correlates with stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 0.3%, with four estimates moving higher and one lower [12] Zacks Rank - UHS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13]

LifeStance Health Group (LFST) closed the last trading session at $6.80, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.75 indicates a 28.7% upside potential.The average comprises eight short-term price targets ranging from a low of $7 to a high of $10, with a standard deviation of $1.07. While the lowest estimate indicates an increase of 2.9% from the current pric ...

Core Viewpoint - Redwood Trust (RWT) shares have increased by 10.1% in the past four weeks, closing at $5.89, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $7.47, representing a 26.8% increase from the current price [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $0.73, where the lowest estimate is $6 (1.9% increase) and the highest is $8.50 (44.3% increase) [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about RWT's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, one estimate has increased while there were no negative revisions, leading to a 9.8% increase in the Zacks Consensus Estimate [12] Zacks Rank and Investment Potential - RWT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside in the near term [13]

Group 1 - The stock of Penguin Solutions, Inc. (PENG) closed at $16.91, reflecting a 4.5% gain over the past four weeks, with a mean price target of $25.06 indicating a potential upside of 48.2% [1] - The average price targets from analysts range from $18 to $30, with a standard deviation of $3.73, suggesting a variability in estimates; the lowest estimate indicates a 6.5% increase, while the highest suggests a 77.4% upside [2] - Analysts have shown increasing optimism regarding PENG's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for PENG's current year earnings has increased by 5.3% over the last 30 days, with two estimates moving higher and no negative revisions [12] - PENG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential for upside in the near term [13] - While price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Group 1 - First Community (FCCO) shares have increased by 5.1% over the past four weeks, closing at $23.70, with a mean price target of $29.67 indicating a potential upside of 25.2% [1] - The average price targets range from a low of $29 to a high of $30, with a standard deviation of $0.58, suggesting a relatively high agreement among analysts [2] - Analysts are optimistic about FCCO's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has historically correlated with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1.1% over the past month, with one estimate rising and no negative revisions [12] - FCCO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Intellia Therapeutics, Inc. (NTLA) closed the last trading session at $8.48, gaining 19.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $41.79 indicates a 392.8% upside potential.The mean estimate comprises 24 short-term price targets with a standard deviation of $27.61. While the lowest estimate of $9 indicates a 6.1% increase from the current price level, the most optimistic a ...

Core Viewpoint - AngioDynamics (ANGO) shares have seen a 1.1% increase over the past four weeks, closing at $9.60, with analysts suggesting a potential upside of 63.2% based on a mean price target of $15.67 [1] Price Targets - The average price target consists of three estimates ranging from a low of $15 to a high of $16, with a standard deviation of $0.58, indicating a strong consensus among analysts [2] - The lowest estimate suggests a 56.3% increase, while the highest indicates a 66.7% upside [2] Analyst Sentiment - Analysts show strong agreement regarding ANGO's ability to report better earnings than previously predicted, which supports the potential for stock upside [4] - A positive trend in earnings estimate revisions has been correlated with stock price movements, suggesting that this could be a reliable indicator of future performance [11] Earnings Estimates - Over the last 30 days, three earnings estimates for ANGO have been revised upward, with no negative revisions, leading to a 22.5% increase in the Zacks Consensus Estimate [12] - ANGO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]